Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Dosing in Multilevel Spinal Surgery
NCT07288697Completed
- Sponsor
- Kartal Dr. Lütfi Kırdar City Hospital
- Start
- Nov 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid (2 arms), sponsored by Kartal Dr. Lütfi Kırdar City Hospital. Primary endpoints: Intraoperative Blood Loss and Number of Patients Requiring Intraoperative Erythrocyte Suspension Transfusion. Started Nov 2023; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT07288697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07288697.